Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07739199 PD-1/VEGF Trispecific Antibody(Harbour) Squamous non-small cell lung cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07739199 clinical trial report covering PD-1/VEGF Trispecific Antibody(Harbour), Phase 2/3, endpoints, sponsor, geography, readout timing and developmen
Read →
Latest Hotspot
8 min read
NCT07739186 PD-1/VEGF Trispecific Antibody(Harbour) Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07739186 clinical trial report covering PD-1/VEGF Trispecific Antibody(Harbour), Phase 2/3, endpoints, sponsor, geography, readout timing and developmen
Read →
Latest Hotspot
8 min read
NCT07742553 Finasteride Hypogonadism Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07742553 clinical trial report covering Finasteride, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07725484 Lipoic acid Coronary Artery Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07725484 clinical trial report covering Lipoic acid, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07723911 Blinatumomab CD19-positive B-cell acute lymphoblastic leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07723911 clinical trial report covering Blinatumomab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
ChiCTR2600128985 Albumin-Bound Paclitaxel Recurrent Squamous Cell Carcinoma of the Head and Neck Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
ChiCTR2600128985 clinical trial report covering Albumin-Bound Paclitaxel, Phase 3, endpoints, sponsor, geography, readout timing and development white spac
Read →
Latest Hotspot
8 min read
NCT07735117 Venetoclax Acute Myeloid Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07735117 clinical trial report covering Venetoclax, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07733765 Ritlecitinib Tosilate Alopecia Areata Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07733765 clinical trial report covering Ritlecitinib Tosilate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07734311 Ecnoglutide Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07734311 clinical trial report covering Ecnoglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07733947 Resveratrol/Curcumin Subcutaneous fat disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07733947 clinical trial report covering Resveratrol/Curcumin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07734844 Tabirafusp alfa tedromer Diabetic macular oedema Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07734844 clinical trial report covering Tabirafusp alfa tedromer, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07734155 Levonorgestrel Contraception Behavior Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07734155 clinical trial report covering Levonorgestrel, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
547
548
549
550
551
>>
1905
>